Novo Nordisk’s Sales Surge: Eyeing $7B Annual Investment
Novo Nordisk sees massive sales jump and expects further growth in 2024, driven by the demand for its diabetes and ...
- Latest
- Trending
Novo Nordisk sees massive sales jump and expects further growth in 2024, driven by the demand for its diabetes and ...
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
Oppenheimer lowers price target on Gilead Sciences after Q4 earnings report and challenges in drug pipeline. Optimistic about prospects for ...
Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...
European companies known as GRANOLAS have proven to be a lower-risk investment, matching the growth of highflying tech giants. With ...
Asian stocks traded in a narrow range due to many major markets being closed for Chinese New Year. Australian market ...
Shares of pharmaceutical firm CSL are set for their worst day in four months as the company announced disappointing results ...
Scientists at Scripps Research have developed a breakthrough technology that allows them to track when brain cells shut off, providing ...
Cure Ventures hires executives from Sage Therapeutics, showcasing the growing interest in neuroscience startups and the potential for advancements in ...
The competition between Johnson & Johnson and Pfizer in the pharmaceutical industry is heating up. Here's a SWOT analysis of ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.